Vimarsana
Biggest News Aggregation in the World

Joint Project Manager News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Joint Project Manager. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Joint Project Manager Today - Breaking & Trending Today

Humanetics Corporation Awarded Contract From Department of Defense to Develop First FDA Approved Dru - Vimarsana News

Humanetics Corporation Awarded Contract From Department of Defense to Develop First FDA Approved Dru

MINNEAPOLIS--(BUSINESS WIRE)--Humanetics Corporation (Humanetics) announced today that it was awarded a 5-year contract from the Department of Defense (DOD) to develop its drug, BIO 300, as a medical countermeasure to prevent bodily harm caused by acute exposure to radiation. The contract is in the form of an Other...

DEVCOM Chemical Biological Center solutions showcased at technology event - Vimarsana News

DEVCOM Chemical Biological Center solutions showcased at technology event

Several chemical and biological defense solutions developed at the U.S. Army Combat Capabilities Development Command Chemical Biological Center were featured at a technology demonstration hosted by the Defense Threat Reduction

DIU to Develop Nasal Spray to Protect Warfighters From Respiratory Viruses - Vimarsana News

DIU to Develop Nasal Spray to Protect Warfighters From Respiratory Viruses

Looking for the latest Government Contracting News? Read about DIU to Develop Nasal Spray to Protect Warfighters From Respiratory Viruses.

Data Safety Monitoring Board Recommends Completion of Phase II Study to Evaluate the Efficacy and Safety of ARAKODA® (tafenoquine) for Treatment of Mild-Moderate Covid-19 Disease - Vimarsana News

Data Safety Monitoring Board Recommends Completion of Phase II Study to Evaluate the Efficacy and Safety of ARAKODA® (tafenoquine) for Treatment of Mild-Moderate Covid-19 Disease

/PRNewswire/ -- 60 Degrees Pharmaceuticals, LLC (60P), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today...

Data Safety Monitoring Board Recommends Completion of Phase II Study to Evaluate the Efficacy and Safety of ARAKODA® (tafenoquine) for Treatment of Mild-Moderate Covid-19 Disease - Vimarsana News

Data Safety Monitoring Board Recommends Completion of Phase II Study to Evaluate the Efficacy and Safety of ARAKODA® (tafenoquine) for Treatment of Mild-Moderate Covid-19 Disease

WASHINGTON, Oct. 12, 2021 /PRNewswire/ -- 60 Degrees Pharmaceuticals, LLC , a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that a Data Safety...